Quantitative Benefit-Risk Assessment of Vaccination Against COVID-19: A Systematic Review.

ABSTRACT:

Purpose

With the introduction of COVID-19 vaccines, there has been a proliferation of quantitative benefit-risk assessments (qBRAs). Prior work on other types of vaccines has found that published qBRAs have not always clearly reported methods and/or results needed to assist in the application of the qBRA findings. The aim was to systematically identify, review, and critically assess published COVID-19 vaccine qBRA. The ultimate goal is to support the future development of robust qBRA for existing, new, and updated vaccines.

Methods

We systematically reviewed COVID-19 vaccine qBRAs identified from multiple sources through April 17, 2023, including literature databases, selected Health Authority websites, and a grey literature search. We critically assessed whether key feature

SUBMITTER: Newbern EC 

PROVIDER: S-EPMC11779546 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature